Hong Kong-led trials show patients with rare liver cancer can live longer by undergoing combined treatments

Six-year study led by Chinese University found that chemotherapy plus targeted radiotherapy could extend patients’ lives by 22 months.

Share this:

What do you think?

Leave a Reply

Your email address will not be published. Required fields are marked *

Written by Headlines

Mainstream media is often "Fake News." Nevertheless, one needs to see what others are seeing and then read with discernment.

Coronavirus: Hong Kong to reveal eased quarantine rules for overseas arrivals at 10.30am

North Korea offers Russia ‘100,000 volunteers’ to fight Ukraine: state media